Fogorvosi szemle, 2014 (107. évfolyam, 1-4. szám)

2014-03-01 / 1. szám

27 FOGORVOSI SZEMLE ■ 107. évf. 1. sz. 2014. Irodalom 1. Carnio J, Camargo PM, Kenney EB, Schenk RK: Histological eval­uation of 4 cases of root coverage following a connective tis­sue graft combined with an enamel matrix derivative preparation. J Periodontol 2002; 73: 1534-1543. 2. Cobb CM: Non-surgical pocket therapy: mechanical. Ann Peri­­odontol 1996; 1: 443-490. 3. Cochran D, King GL, Schoolfield J, Velasquez-Plata D, Mellonig JT, Jones A: Effect of enamel matrix proteins on periodontol regene­ration as determined by histological analysis. J. Periodontol 2003; 74:1043-1055. 4. Cortellini P: Minimally invasive surgical techniques in periodon­tal regeneration. J Evid Based Dent Pract 2012; 12(3): 89-100. 5. Dori F, Arweiler N, Húszár T, Gera I, Miron R, Sculean A: Five Year Results Evaluating the Effects of Platelet-Rich Plasma on the Healing of Intrabony Defects Treated With an Enamel Matrix Derivative and a Natural Bone Mineral. J Periodontol2013 Jan. 6. Froum SJ, Weinberg MA, Rosenberg E, Tarnow D: A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study. J Periodontol 2001; 72: 25-34. 7. Gottlow J, Nyman S, Karring T, Lindhe J: New attachment forma­tion as the result of controlled tissue regeneration. J Clin Peri­odontol. 1984; 11(8): 494-503. 8. Heul L, Heden G, Svardström G, Östgren A: Enamel matrix derivative (Emdogain®) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24: 705-714. 9. Hung HC, Douglass CW: Meta-analysis of the effect of scaling and root planing, surgical treatment and antibiotic therapies on periodontal probing depth and attachment loss. J Clin Periodontol 2002; 29: 975-986. 10. Kornman KS, Robertson PB: Clinical and microbiological evalu­ation of therapy for juvenile periodontitis. J Periodontol 1985; 56: 443-446. 11. Kyriazis T, Gkrizioti S, Mikrogeorgis G, Tsalikis L, Sakellari D, Lyroudia K, Konstantinides A: Crestal bone resorption after the application of two periodontal surgical techniques: a rand­omized, controlled clinical trial. J Clin Periodontol2012; 39(10): 971-978. 12. Lang NP, Bartold PM, Culliman M, Jeffcoat M, et al: International Classification Workshop Consensus report: Aggressive periodon­titis. Ann Periodontol 1999;4:53. 13. Miyaji H, SugayaT, Ibe K, Ishizuka R, Tokunaga K, Kawanami M: Root | surface conditioning with bone morphogenetic protein-2 facilitates cementum-like tissue deposition in beagle dogs. J Periodontal Res. 2010; 45(5): 658-663. 14. Mazjoub Z, Bobbo M, Atiyeh F, Cordioli G: Two patterns of his­tologic healing in an intrabony defect following treatment with an enamel matrix derivative: a human case report. Int J Periodontics Restorative Dent 2005; 25: 283-294. 15. Okuda K, Momose M, Miyazaki A, Murata M, Yokohama S, Yonezawa Y, Wolff LF, Yoshie H: Enamel matrix derivative in the treatment of hu­man intrabony osseous defects. J Periodontol2000; 71:1821-1828. 16. Pontoriero R, wennström J, lindhe J: The use of barrier mem­branes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. J Clin Peri­­odontol 1999; 26: 833-840. 17. Rasperini G, Silvestri M, Schenk RK, Nevins ML: Clinical and histo­logical evaluation of human gingival recession treated with a sub­­epithelial connective tissue graft and enamel matrix derivative (Emdogain): a case report. Int J Periodontics Restorative Dent 2000; 20: 269-275. 18. Renvert S, Wikström M, Dahlen G, Slots J, Egelberg J: On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets. J Clin Periodontol 1990; 17: 351-355. 19. Rösing CK, Aass AM, Mavropoulos A, Gjermo P: Clinical and ra­diographic effects of enamel matrix derivative in the treatment of intrabony periodontal defects: a 12-month longitudinal placebo­­controlled clinical trial in adult periodontitis patients. J Periodontol 2005; 76: 129-133. 20. Scheyer ET, Velasquez-Plata D, Brunsvold MA, Lasho DJ, Mel­lonig JT: A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans. J Peri­odontol 2002; 73: 423-432. 21. Sculean A, Barbé G, Chiantella GC, Arweiler NB, Berakdar M, Brecx M: Clinical evaluation of an enamel matrix protein deriv­ative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. J Periodontol 2002; 73: 401- 408. 22. Sculean A, Chiantella GC, Windisch P, Donos N: Clinical and his­tologic evaluation of treatment of intrabony defects with an enamel matrix protein derivative (Emdogain®). Int J Periodont Rest Dent 2000; 20: 375-381. 23. Sculean A, Chiantella GC, Windisch P, Gera I, Reich E: Clinical evaluation of an enamel matrix protein derivative (Emdogain®) combined with a bovine derived xenograft (Bio-Oss®) for the treat­ment of intrabony periodontal defects in humans. Int J Periodont Rest Dent 2002; 22: 259-267. 24. Sculean A, Donos N, Brecx M, Reich E, Karring T: Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 2000; 27: 466-472. 25. Sculean A, Donos N, Reich E, Brecx M, Karring T: Healing of re­­cession-type defects following treatment with enamel matrix pro­teins or guided tissue regeneration. A pilot study in monkeys. J Pa­­rodontol Implant Orale 2000; 19: 19-31. 26. Sculean A, Windisch P, Chiantella GC, Donos N, Brecx M, Reich E: Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study. J Clin Periodontol 2001 ; 28: 397-403. 27. Sculean A, Windisch P, Keglevich T, Chiantella GC, Gera I, Donos N: Clinical and histologic evaluation of human intrabony defects treated with an enamel matrix protein derivative combined with a bovine-derived xenograft. Int J Periodontics Restorative Dent 2003; 23: 47-55. 28. Sculean A, Windisch P, Keglevich T, Gera I: Clinical and histologi­cal evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans. Int J Periodont Rest Dent 2005; 25: 139-147. 29. Silvestri M, Ricci G, Rasperini G, Sartori S, Cattaneo V: Com­parison of treatments of intrabony defects with enamel matrix de­rivative, guided tissue regeneration with a nonresorbable mem­brane and Widman modified flap. A pilot study. J Clin Periodontol 2000; 27: 603-610. 30. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V: Comparison of intarbony defects treated with enamel matrix de­rivative versus guided tissue regeneration with a nonresorbable membrane. J Clin Periodontol 2003; 30: 386-393. 31. Slots J, Mashimo P, Levine MJ, Genco RJ: Periodontal therapy in humans. I Microbiological and clinical effects of a single course of periodontal scaling and root planing and of adjunctive tetra­cycline therapy. J Periodontol 1979; 23: 260-269. 32. Slots J, Rosling BG: Suppression of the periodontopathic micro­flora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1983; 10: 465-486. 33. Suvan JE: Effectiveness of mechanical nonsurgical pocket therapy. Periodontol 2000 2005; 37: 48-71. 34. Tonetti Ms, Fourmousis I, Sauvan J, Cortellini P, Brägger U, Lang Np: Healing, post-operative morbidity and patient perception of outcomes following regenerative therapy of deep intrabony de­fects. J Clin Periodontol 2004; 31: 1092-1098. 35. Tonetti MS, Lang NP, Cortellini P, Suvan JE, et. al.: Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicenter randomized controlled clinical trial. J Clin Periodontol 2002; 29: 317-325.

Next

/
  • Layout
  • Zoom
  • Rotation
Thumbnails
Contents